NGeneBio participated in MEDLAB 2023, the largest medical equipment exhibition in the Middle East region, held at the Dubai World Trade Center from February 6 to February 9, 2023.

At this exhibition, NGeneBio showcased the outstanding performance and market competitiveness of a wide range of precision diagnostic products, including HEMEaccuTest™ for blood cancer, ONCOaccuPanel™ for solid cancer, BRCAaccuTest™PLUS for breast and ovarian cancer, HLAaccuTest™ All for tissue compatibility antigens, MTBaccuPanel™ for tuberculosis, and NGeneAnaySys™ for disease genomics analysis software.

Furthermore, NGeneBio conducted partnership meetings to fortify its presence in the NGS market in the Middle East and Africa, with the goal of expanding its global network. Leveraging its differentiated technology, NGeneBio is poised to lead the Middle East and Africa markets while also extending its reach into Europe and the Americas, thereby creating new business opportunities.

For more detailed information about MEDLAB 2023, please visit www.medlabme.com